Andreas M Schneider1, Ralph W Aye2, Candice L Wilshire1, Alexander S Farivar1, Brian E Louie1. 1. Division of Thoracic Surgery, Swedish Cancer Institute and Medical Center, 1101 Madison St. Suite 900, Seattle, WA, 98104, USA. 2. Division of Thoracic Surgery, Swedish Cancer Institute and Medical Center, 1101 Madison St. Suite 900, Seattle, WA, 98104, USA. ralph.aye@swedish.org.
Abstract
BACKGROUND: A randomized controlled trial (RCT) showed that laparoscopic Nissen fundoplication (LNF) and Hill (LHR) repairs are equivalent in treating uncomplicated GERD. We combined both repairs to create a laparoscopic Nissen-Hill Hybrid repair (HYB). The purpose of this study is to compare clinical and objective outcomes of a matched group of HYB to the two cohorts of the RCT. METHODS: A retrospective analysis of prospectively collected data from the RCT and a prospectively collected data base was performed. Data were collected preoperatively, postoperatively short-term (ST) at 6 weeks and mid-term (MT) at 6-12 months. Evaluation was standardized according to the RCT and included three quality of life metrics (QOLRAD, GERD-HRQL, Dysphagia), endoscopy, manometry, pH testing, and barium swallow. RESULTS: There were 51 HYB, 46 LNF, and 56 LHR patients. Age, BMI, follow-up, and gender were comparable. QOLRAD, HRQL, PPI use, DeMeester scores, and pH% time <4 significantly improved in all groups and were equivalent. Anatomic recurrence was seen in five LNF, four LHR, and two HYB patients. Reoperations were performed in three LHR, two LNF, and zero HYB patients. CONCLUSION: Tri-comparison shows that HYB is a promising alternative to LHR and LNF. Side effects were not increased and there were fewer reoperations for failure.
RCT Entities:
BACKGROUND: A randomized controlled trial (RCT) showed that laparoscopic Nissen fundoplication (LNF) and Hill (LHR) repairs are equivalent in treating uncomplicated GERD. We combined both repairs to create a laparoscopic Nissen-Hill Hybrid repair (HYB). The purpose of this study is to compare clinical and objective outcomes of a matched group of HYB to the two cohorts of the RCT. METHODS: A retrospective analysis of prospectively collected data from the RCT and a prospectively collected data base was performed. Data were collected preoperatively, postoperatively short-term (ST) at 6 weeks and mid-term (MT) at 6-12 months. Evaluation was standardized according to the RCT and included three quality of life metrics (QOLRAD, GERD-HRQL, Dysphagia), endoscopy, manometry, pH testing, and barium swallow. RESULTS: There were 51 HYB, 46 LNF, and 56 LHRpatients. Age, BMI, follow-up, and gender were comparable. QOLRAD, HRQL, PPI use, DeMeester scores, and pH% time <4 significantly improved in all groups and were equivalent. Anatomic recurrence was seen in five LNF, four LHR, and two HYB patients. Reoperations were performed in three LHR, two LNF, and zero HYB patients. CONCLUSION: Tri-comparison shows that HYB is a promising alternative to LHR and LNF. Side effects were not increased and there were fewer reoperations for failure.
Entities:
Keywords:
Fundoplication; Gastroesophageal reflux; Quality of life; Recurrence; Reoperation
Authors: Nicholas R A Symons; Sanjay Purkayastha; Bruno Dillemans; Thanos Athanasiou; George B Hanna; Ara Darzi; Emmanouil Zacharakis Journal: Am J Surg Date: 2011-07-23 Impact factor: 2.565
Authors: Ralph W Aye; Alia P Qureshi; Candice L Wilshire; Alexander S Farivar; Eric Vallières; Brian E Louie Journal: Surg Endosc Date: 2015-06-12 Impact factor: 4.584
Authors: Omar Awais; James D Luketich; Matthew J Schuchert; Christopher R Morse; Jonathan Wilson; William E Gooding; Rodney J Landreneau; Arjun Pennathur Journal: Ann Thorac Surg Date: 2011-07-29 Impact factor: 4.330
Authors: Erica Cohen; Roger Bolus; Dinesh Khanna; Ron D Hays; Lin Chang; Gil Y Melmed; Puja Khanna; Brennan Spiegel Journal: Dig Dis Sci Date: 2014-05-09 Impact factor: 3.199
Authors: Lars Lundell; Pekka Miettinen; Helge E Myrvold; Jan G Hatlebakk; Lene Wallin; Cecilia Engström; Risto Julkunen; Madeline Montgomery; Anders Malm; Tore Lind; Anders Walan Journal: Clin Gastroenterol Hepatol Date: 2009-05-31 Impact factor: 11.382